Sit back and listen to Dr. Fredrik Schjesvold talking about the importance of clinical studies in the Nordics. How to be an attractive partner for early phase studies? And what kind of progress is being made to predict how well patients respond to treatment and the ability to identify the best, least toxic treatment option.